Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 70 pages
Exam (elaborations)

NURS 6521 ADVANCED PHARMACOLOGY FINAL EXAM– QUESTIONS AND ANSWERS | VERIFIED AND WELL DETAILED ANSWERS PLUS RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE | EXAM PREP | STUDY GUIDE | PRACTICE TEST| DOWNLOAD INSTANT PDF

Document preview thumbnail
Preview 4 out of 70 pages

NURS 6521 ADVANCED PHARMACOLOGY FINAL EXAM– QUESTIONS AND ANSWERS | VERIFIED AND WELL DETAILED ANSWERS PLUS RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE | EXAM PREP | STUDY GUIDE | PRACTICE TEST| DOWNLOAD INSTANT PDF

Content preview

NURS 6521 ADVANCED PHARMACOLOGY FINAL EXAM–
QUESTIONS AND ANSWERS | VERIFIED AND WELL DETAILED
ANSWERS PLUS RATIONALES | GUARANTEED PASS | LATEST
EXAM UPDATE | EXAM PREP | STUDY GUIDE | PRACTICE
TEST| DOWNLOAD INSTANT PDF
1. A 62-year-old male with a history of chronic stable angina and heart failure is initiated
on carvedilol therapy. The advanced practice registered nurse understands that carvedilol
provides dual cardiovascular benefits due to which unique pharmacological mechanism?

A. Selective beta-1 blockade combined with intrinsic sympathomimetic activity
B. Non-selective beta blockade, alpha-1 blockade, and antioxidant properties
C. Direct vasodilation via calcium channel antagonism and beta-2 stimulation
D. Inhibition of angiotensin-converting enzyme coupled with aldosterone antagonism

ANSWER: B. Non-selective beta blockade, alpha-1 blockade, and antioxidant properties

Carvedilol is a third-generation beta-blocker that uniquely blocks beta-1, beta-2, and alpha-1
adrenergic receptors. The alpha-1 blockade causes vasodilation, reducing afterload, while its
antioxidant properties protect myocardial tissue from ischemic damage. Option A is incorrect
because carvedilol lacks intrinsic sympathomimetic activity and is non-selective. Option C
describes calcium channel blockers, and Option D describes ACE inhibitors and
mineralocorticoid receptor antagonists.

2. An advanced practice nurse practitioner is evaluating a 54-year-old female with newly
diagnosed type 2 diabetes mellitus and stage 3 chronic kidney disease (eGFR 45
mL/min/1.73m2). Which antidiabetic agent is most appropriate to initiate to provide both
glycemic control and renal protection?

A. Metformin
B. Empagliflozin
C. Glyburide
D. Glimepiride

ANSWER: B. Empagliflozin

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, such as empagliflozin, provide robust
renal protection by reducing intraglomerular pressure and slowing the progression of diabetic
kidney disease, making them ideal for patients with stage 3 CKD. Metformin (Option A)
requires dose adjustment or discontinuation if eGFR drops below specific thresholds due to
lactic acidosis risk. Glyburide and glimepiride (Options C and D) are sulfonylureas carrying a
high risk of prolonged hypoglycemia in renal impairment.

,3. A 70-year-old male is prescribed warfarin for stroke prevention secondary to chronic
atrial fibrillation. Laboratory monitoring reveals an INR of 4.8 with no signs of active
bleeding. What is the most appropriate immediate management strategy according to
current clinical guidelines?

A. Administer high-dose intravenous vitamin K and fresh frozen plasma immediately.
B. Permanently discontinue warfarin and transition to antiplatelet therapy.
C. Withhold the next one to two doses of warfarin, monitor INR closely, and resume at an
adjusted lower dose once the INR returns to the therapeutic range.
D. Double the daily dose of warfarin to accelerate clearance.

ANSWER: C. Withhold the next one to two doses of warfarin, monitor INR closely, and
resume at an adjusted lower dose once the INR returns to the therapeutic range.

For patients with an INR between 4.5 and 10.0 without evidence of bleeding, current
guidelines recommend withholding the next 1-2 doses, monitoring serial INRs, and resuming
therapy at a reduced dose. Vitamin K and reversal agents (Option A) are reserved for major
bleeding or significantly elevated INRs with bleeding risk. Stopping warfarin entirely (Option
B) leaves the patient vulnerable to thromboembolism, and doubling the dose (Option D) would
dangerously elevate the INR further.

4. A nurse practitioner is managing a 45-year-old female with moderate persistent asthma.
The patient is currently using an inhaled short-acting beta-2 agonist as needed. Which
medication class should be added as the preferred long-term controller therapy?

A. Oral leukotriene receptor antagonist monotherapy
B. Low-dose inhaled corticosteroid
C. Long-acting muscarinic antagonist monotherapy
D. Systemic oral corticosteroid burst therapy

ANSWER: B. Low-dose inhaled corticosteroid

Low-dose inhaled corticosteroids (ICS) are the gold-standard, preferred first-line controller
medication for persistent asthma due to their potent anti-inflammatory effects on airway
remodeling. Leukotriene receptor antagonists (Option A) are alternative, less effective
controllers. Long-acting muscarinic antagonists (Option C) are typically added later or used
primarily in COPD, and oral corticosteroids (Option D) are reserved for acute exacerbations,
not chronic maintenance, due to severe systemic side effects.

5. A 68-year-old male presents with severe acute gouty arthritis affecting the first
metatarsophalangeal joint. His medical history includes active peptic ulcer disease and
severe renal impairment (CrCl 25 mL/min). Which therapeutic agent is contraindicated for
managing this acute attack?

A. Colchicine
B. Indomethacin

,C. Intra-articular triamcinolone
D. Prednisone taper

ANSWER: B. Indomethacin

Nonsteroidal anti-inflammatory drugs (NSAIDs) like indomethacin are strictly
contraindicated in patients with active peptic ulcer disease due to gastrointestinal ulceration
and bleeding risks, as well as in significant renal impairment due to nephrotoxicity.
Colchicine (Option A) can be used with severe renal dose adjustments. Intra-articular
corticosteroids (Option C) and systemic steroid tapers (Option D) are safe and effective
alternatives for patients who cannot tolerate NSAIDs or colchicine.

6. An advanced practice nurse is prescribing levothyroxine for a 38-year-old female
diagnosed with primary hypothyroidism. What essential patient education should be
provided regarding optimal drug absorption and administration?

A. Take the medication immediately following a high-fat breakfast to enhance lipid solubility.
B. Take the medication on an empty stomach with a full glass of water, at least 30 to 60 minutes
before breakfast.
C. Crush the tablet and mix it into morning coffee or calcium-fortified orange juice.
D. Take the medication at bedtime concurrently with ferrous sulfate supplements.

ANSWER: B. Take the medication on an empty stomach with a full glass of water, at least
30 to 60 minutes before breakfast.

Levothyroxine absorption is significantly impaired by food, calcium, iron, and coffee;
therefore, it must be taken on an empty stomach with water 30-60 minutes prior to eating.
Options A and C violate absorption guidelines, and Option D introduces concurrent iron
supplementation, which binds levothyroxine in the gastrointestinal tract and prevents
absorption.

7. A 60-year-old male with heart failure with reduced ejection fraction (HFrEF) is
prescribed sacubitril/valsartan. Before initiating this medication, what required washout
period is mandatory if the patient was previously taking lisinopril?

A. No washout period is required; transition can occur immediately.
B. A 24-hour washout period is required.
C. A 36-hour washout period is required.
D. A 14-day washout period is required.

ANSWER: C. A 36-hour washout period is required

A mandatory 36-hour washout period between ACE inhibitors (like lisinopril) and
sacubitril/valsartan is required to drastically reduce the risk of angioedema caused by
simultaneous ACE and NEP inhibition. Option A is dangerous, Option B is insufficient, and
Option D exceeds the required duration.

, 8. An advanced practice registered nurse is evaluating a 50-year-old male started on
lisinopril two weeks ago. The client complains of a persistent, dry, hacking cough. What is
the underlying pharmacological mechanism responsible for this adverse effect?

A. Blockade of histamine H1 receptors in the bronchial tree
B. Accumulation of bradykinin and substance P due to ACE inhibition
C. Direct stimulation of beta-2 adrenergic receptors in airway smooth muscle
D. Inhibition of cyclooxygenase pathways leading to leukotriene overproduction

ANSWER: B. Accumulation of bradykinin and substance P due to ACE inhibition

ACE inhibitors block the degradation of bradykinin and substance P. Their accumulation in
the respiratory tract leads to local irritation and the characteristic dry cough. Options A, C,
and D describe mechanisms related to antihistamines, beta-agonists, and NSAIDs,
respectively.

9. A nurse practitioner is treating a 72-year-old female with osteoporosis who is prescribed
bisphosphonate therapy. Which counseling instruction is critical to prevent severe
esophageal adverse events?

A. Lie flat in bed immediately after taking the tablet with a small sip of milk.
B. Chew the tablet thoroughly before swallowing to enhance gastric dissolution.
C. Swallow the tablet whole with a full glass of plain water upon arising, and remain upright
without eating or drinking for at least 30 minutes.
D. Take the medication concurrently with a multivitamin containing high amounts of calcium
and magnesium.

ANSWER: C. Swallow the tablet whole with a full glass of plain water upon arising, and
remain upright without eating or drinking for at least 30 minutes.

Bisphosphonates are potent esophageal irritants; remaining upright and fasting prevents
esophageal reflux, erosion, and ulceration. Option A promotes reflux, Option B destroys the
delayed-release enteric coating or causes mucosal damage, and Option D impairs
bisphosphonate absorption.

10. A 28-year-old pregnant female at 24 weeks gestation is diagnosed with essential
hypertension. Which antihypertensive medication class is strictly contraindicated due to
documented teratogenic risks, including fetal renal failure and oligohydramnios?

A. Beta-blockers (e.g., labetalol)
B. Calcium channel blockers (e.g., nifedipine)
C. Angiotensin receptor blockers (ARBs)
D. Centrally acting alpha-2 agonists (e.g., methyldopa)

ANSWER: C. Angiotensin receptor blockers (ARBs)

Document information

Uploaded on
July 30, 2026
Number of pages
70
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$25.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
0
Followers
0
Items
282
Last sold
-


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions